MoneyWorks4Me

Ind-Swift Laboratories informs about disclosure

04 Jul 2025 Evaluate
Ind-Swift Laboratories has informed that it enclosed disclosure under Regulation 29(1) of SEBI (Substantial acquisition of Shares and Takeover) Regulations, 2011 received by the Company on 3rd July, 2025 from Zeal Global Opportunities Fund.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..